Literature DB >> 8167176

Proteolytic processing of von Willebrand factor subunit: heterogeneity in type-IIA von Willebrand disease.

J Batlle1, J Lasierra, A F Villamor, J L Navarro, A Pardo, M Campos, B Justiça, M F López Fernández.   

Abstract

Type IIA von Willebrand disease (vWD) is a heterogeneous disorder for which two different pathogenetic mechanisms have been proposed: increased proteolytic susceptibility of von Willebrand factor (vWF), and/or interference of its post-translational processing. Subunit analysis of vWF in type-IIA vWD has revealed an increased relative proportion of the 176- and 140-kDa subunit-derived fragments, suggesting an augmented fragmentation of vWF, even in the resting state. We analyzed the subunit pattern of vWF in plasma from five previously described patients with type-IIA vWD. All of them showed the above-mentioned pattern. In addition, the presence of a new band with an apparent molecular mass of 200 kDa, not described in normal individuals or in patients with vWD, was repeatedly observed in one of these patients. This patient also exhibited an abnormal vWF multimeric structure in platelets and in plasma, before and after desmopressin administration, when the blood was collected either in the presence or in the absence of proteinase inhibitors. We believe that an abnormal primary structure of vWF could be responsible for this abnormal proteolytic fragmentation pattern, as well as for the abnormal multimerization of vWF. Moreover, an abnormal susceptibility to proteolysis appears to be present, as suggested by the increase in the relative proportion of the 176-kDa fragment observed in the same patient. Future sequencing studies and genetic analysis may clarify whether there are one or two different defects related to the vWF of that patient. Our results indicate that the subunit analysis of vWF may reveal additional defects present in type-IIA vWD that may help our understanding of the pathogenesis of such disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167176     DOI: 10.1007/bf01727414

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  20 in total

1.  Secretion of von Willebrand factor from platelets.

Authors:  M F Lopez-Fernandez; J Batlle; Z M Ruggeri; T S Zimmerman
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

2.  Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

Authors:  D Ginsburg; B A Konkle; J C Gill; R R Montgomery; P L Bockenstedt; T A Johnson; A Y Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  von Willebrand factor and von Willebrand disease.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

5.  Unique expression of von Willebrand factor by type IIA von Willebrand's disease endothelial cells.

Authors:  B Wilbourn; P Harrison; A Lawrie; F LeRoy; M Rowley; D Bevan; A Inbal; G Savidge
Journal:  Br J Haematol       Date:  1992-07       Impact factor: 6.998

6.  Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

Authors:  T S Zimmerman; J A Dent; Z M Ruggeri; L H Nannini
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  Type IIB von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy.

Authors:  M F López-Fernández; C López-Berges; J A Martín-Bernal; R Sánchez; L G Villarón; J Díez-Jarilla; J Batlle
Journal:  Am J Hematol       Date:  1988-04       Impact factor: 10.047

8.  In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease.

Authors:  H R Gralnick; S B Williams; L P McKeown; P Maisonneuve; C Jenneau; Y Sultan; M E Rick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Abnormal proteolytic degradation of von Willebrand factor after desmopressin infusion in a new subtype of von Willebrand disease (ID).

Authors:  M F Lopez-Fernandez; R Gonzalez-Boullosa; M J Blanco-Lopez; M Perez; J Batlle
Journal:  Am J Hematol       Date:  1991-03       Impact factor: 10.047

10.  Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin.

Authors:  S D Berkowitz; J Dent; J Roberts; Y Fujimura; E F Plow; K Titani; Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.